Overview Financials News + Filings Key Docs Charts Ownership Insiders |
Crexendo, Inc. (CXDO)
|
Add to portfolio |
|
|
Price: |
$6.45
| | Metrics |
OS: |
26.0
|
M
| |
-86
|
% ROE
|
Market cap: |
$168
|
M
| |
-44
|
% ROIC
|
Net debt:
|
$5.54
|
M
| |
|
|
EV:
|
$173
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
($1.2)
|
M
| |
|
|
EBIT
|
($4.6)
|
M
| |
|
|
EPS |
($1.53)
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
Revenues | 37.6 | 28.1 | 16.4 | 14.4 | 11.9 | 10.2 | 9.1 | 7.8 |
Revenue growth | 33.7% | 71.4% | 13.5% | 21.2% | 16.9% | 11.7% | 16.6% | 3.0% |
Cost of goods sold | 8.3 | 6.6 | 4.9 | 4.4 | 3.8 | 3.3 | 3.6 | 3.6 |
Gross profit | 29.2 | 21.5 | 11.4 | 10.1 | 8.1 | 6.9 | 5.5 | 4.2 |
Gross margin | 77.8% | 76.4% | 69.8% | 69.9% | 67.9% | 67.9% | 60.2% | 54.3% |
Sales and marketing | 11.7 | 8.3 | 4.2 | 3.9 | 3.4 | 2.8 | 2.5 | 2.4 |
Research and development | 4.0 | 1.4 | 1.2 | 0.9 | 0.8 | 0.8 | 0.8 | 0.8 |
General and administrative | 13.0 | 10.7 | 5.1 | 4.2 | 4.1 | 4.1 | 4.9 | 5.9 |
EBITA | -4.7 | -2.8 | 1.0 | 1.4 | -0.2 | -0.7 | -2.8 | -4.8 |
EBITA margin | -12.6% | -10.0% | 6.0% | 9.4% | -1.7% | -7.2% | -30.3% | -61.9% |
Amortization of intangibles | | | | 0.1 | | | | |
EBIT | -4.7 | -2.8 | 1.0 | 1.3 | -0.2 | -0.7 | -2.8 | -4.8 |
EBIT margin | -12.6% | -10.0% | 6.0% | 9.1% | -1.7% | -7.2% | -30.3% | -61.9% |
Pre-tax income | -36.2 | -2.9 | 1.9 | 1.1 | -0.2 | -1.0 | -2.8 | -4.6 |
Income taxes | -0.8 | -0.5 | -6.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 2.1% | 16.0% | | 0.5% | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | -35.4 | -2.4 | 7.9 | 1.1 | -0.2 | -0.9 | -2.8 | -4.5 |
Net margin | -94.3% | -8.7% | 48.5% | 7.9% | -1.9% | -9.1% | -30.6% | -58.0% |
|
Diluted EPS | ($1.54) | ($0.12) | $0.46 | $0.07 | ($0.02) | ($0.07) | ($0.21) | ($0.35) |
Shares outstanding (diluted) | 22.9 | 20.3 | 17.4 | 15.6 | 14.3 | 13.9 | 13.4 | 13.0 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|